A clinical-stage biopharmaceutical company focused on therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance.
Boston, MA, United States~82 employeesFounded Jan 2015Website
BiotechnologyCentral Nervous System DisordersTherapies